Previously, we have showed that GXD ameliorated heart injury and protected rats from myocardial fibrosis, which may be related to inhibiting the TGF-β1 signaling pathway by down-regulating expressions of Smad2/3 whereas improving Smad7 expression. Here, SMAD2 is linked to Myocardial fibrosis.